ACS Pharmacology & Translational Science · 2020 · 55 citations · 16 references
Life SciencesBiochemistryMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral TherapyEnzyme InhibitionProteolytic EnzymesCatalytic Site ArchitectureSars-cov-2 Antiviral TherapySars-cov-2 InfectionViral Protease InhibitionViral ProteasesViral Replication ControlViral Replication InhibitionViral Replication Inhibitors
), which play key roles for viral replication and hence represent promising drug targets. In this Viewpoint, both sulfur-based drugs and peptides-based inhibitors may block Cys residues in the catalytic and/or Zn site of CoV-2-PLpro, leading to dysfunction of CoV-2-PLpro and thereby halting viral replication.
16
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan, Jiwan Ge, Jinfang Yu et al. · Nature · 2020 · 6.7K citations · Full text
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang, Gang Ye, Ke Shi et al. · Nature · 2020 · 4.1K citations · Full text
Coronavirus Main Proteinase (3CL <sup>pro</sup> ) Structure: Basis for Design of Anti-SARS Drugs
K. Anand, John Ziebuhr, Parvesh Wadhwani et al. · Science · 2003 · 1.8K citations